why choose us

First received: May 16, 2023

Clinical Trial: Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Weight Loss

Study Type: INTERVENTIONAL


Official Title: Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose

Brief Summary: The use of continuous glucose monitoring (CGM) in earlier data has inspired behavioral changes leading to improved adherence to an exercise plan in individuals and eating habits in people with diabetes.Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools to help participants in the pursuit of weight change goals.We hypothesize that the use of CGM data and the Signos mHealth platform will assist with weight control in a population of people with type 2 diabetes mellitus who are not using…

Read more